Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease



Hernandez-Romero, Diana, Sanchez-Quinones, Jessica, Antonio Vilchez, Juan, Miguel Rivera-Caravaca, Jose, de la Morena, Gonzalo, Lip, Gregory YH ORCID: 0000-0002-7566-1626, Climent, Vicente and Marin, Francisco
(2019) Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease. SCIENTIFIC REPORTS, 9 (1). 6235-.

Access the full-text of this item by clicking on the Open Access link.

Abstract

Current therapies have not shown benefit in organ damage reversal in Fabry disease (FD), but biomarkers could help risk stratification and prognosis. We investigated if several biomarkers of cardiac fibrosis, cardiac wall stress, myocardial injury, renal function and inflammation, are associated with early cardiac affectation in FD patients. We included FD patients from four cardiology outpatient clinics of southeastern Spain. At inclusion, Galectin-3 (Gal-3), N-terminal proB-type natriuretic peptide, high sensitivity troponin T (hsTnT), β-trace protein (BTP) and interleukin-6 concentrations were measured. The relation of biomarkers concentrations with clinical features, cardiac involvement and organ affectation according to the Mainz Severity Score Index (MSSI) was investigated. 44 FD patients (n = 21 affected and n = 23 unaffected) were compared to age and sex-respectively matched healthy controls. Significant differences in biomarkers' concentration between FD groups were observed. Importantly, Gal-3 and BTP levels were higher in unaffected patients when compared with age and sex-matched healthy controls (both p < 0.05). All the biomarkers correlated with clinical features. When cut-off values for clinical affectation (measured as MSSI ≥ 20) were established, only hsTnT (OR 30.69, 95% CI 2.70-348.42) and male sex (OR 8.17, 95% CI 1.16-57.75) were independently associated with cardiac damage by multivariate regression analysis. Gal-3 and BTP levels are increased in unaffected FD patients compared to healthy controls. This suggests that these biomarkers could be useful for the early detection of cardiac affectation in FD patients. On the other hand, hsTnT and male sex are independent risk factors for established clinical cardiac damage in FD.

Item Type: Article
Uncontrolled Keywords: Humans, Fabry Disease, Natriuretic Peptide, Brain, alpha-Galactosidase, Intramolecular Oxidoreductases, Peptide Fragments, Blood Proteins, Troponin T, Galectins, Galectin 3, Interleukin-6, Prognosis, Risk Factors, Mutation, Adult, Middle Aged, Spain, Female, Male, Lipocalins, Young Adult, Healthy Volunteers, Biomarkers
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Faculty Management Office
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 30 Jun 2021 10:00
Last Modified: 10 Oct 2023 20:23
DOI: 10.1038/s41598-019-42727-4
Open Access URL: http://doi.org/10.1038/s41598-019-42727-4
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3128241